Showing results (201-210 of 334) with videos related to

Sort By:
Pageof 34
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsClotilde Allavena, Virginie Ferré, Cécile Brunet-François, et al.
AIDS Research and Human Retroviruses|November 13, 2008
Short communication: Long-term persistence of vaccine-induced HIV seropositivity among healthy volunteersBenjamin Silbermann, Michel Tod, Corinne Desaint, et al.
Plos One|October 20, 2010
French experience of 2009 A/H1N1v influenza in pregnant womenGrégory Dubar, Elie Azria, Antoine Tesnière, et al.
Vaccine|July 25, 2018
A report on the status of vaccination in EuropeShazia Sheikh, Eliana Biundo, Soizic Courcier, et al.
BMC Infectious Diseases|May 16, 2019
Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance NetworkJoan Puig-Barberà, Ainara Mira-Iglesias, Elena Burtseva, et al.
AIDS (London, England)|August 11, 2018
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patientsNathalie Colin de Verdiere, Christine Durier, Assia Samri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1Odile Launay, Laurence Gérard, Laurence Morand-Joubert, et al.
Human Vaccines & Immunotherapeutics|March 28, 2023
Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trialIlaria Galgani, Airi Põder, Rain Jõgi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 28, 2017
The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica pleuropneumonia in a patient with diffuse large B-cell lymphomaEtienne Canouï, Kim Blanc, Julien Loubinoux, et al.
Vaccine|July 16, 2013
Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16)Odile Launay, Mathieu Surenaud, Corinne Desaint, et al.
Pageof 34